Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DISEASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | DISEASE |
| Key Genes/Proteins | SIRTUINS |
Knowledge base pages for this entity
graph TD
DISEASE["DISEASE"]
autophagy["autophagy"] -.protects against.-> DISEASE
RAB7A["RAB7A"] -->|"implicated in"| DISEASE
LRP2["LRP2"] -->|"implicated in"| DISEASE
ACTB["ACTB"] -->|"implicated in"| DISEASE
CTSD["CTSD"] -->|"implicated in"| DISEASE
ATG["ATG"] -->|"implicated in"| DISEASE
EGFR["EGFR"] -->|"implicated in"| DISEASE
SREBF1["SREBF1"] -->|"implicated in"| DISEASE
NADH["NADH"] -->|"implicated in"| DISEASE
MTORC1["MTORC1"] -->|"implicated in"| DISEASE| Target | Relation | Type | Str |
|---|---|---|---|
| Organ Dysfunction | causes | phenotype | 0.95 |
| Synaptic Dysfunction | associated_with | mechanism | 0.95 |
| Aberrant Proteostasis | associated_with | mechanism | 0.95 |
| Rna Defects | associated_with | mechanism | 0.95 |
| Neuronal Network Dysfunction | associated_with | mechanism | 0.95 |
| Altered Energy Homeostasis | associated_with | mechanism | 0.95 |
| Dna Defects | associated_with | mechanism | 0.95 |
| Cytoskeletal Abnormalities | associated_with | mechanism | 0.95 |
| Pathological Protein Aggregation | associated_with | mechanism | 0.95 |
| DENDRITE | protects_against | concept | 0.50 |
| Retinopathy | associated_with | disease | 0.50 |
| FRONTAL | associated_with | concept | 0.50 |
| MACROPHAGES | regulates | concept | 0.50 |
| TRIM21 | causes | concept | 0.50 |
| Reactive Oxygen Species | causes | process | 0.50 |
| Liver Cancer | associated_with | disease | 0.50 |
| MOTOR NEURON | causes | concept | 0.50 |
| ISCHEMIC | regulates | concept | 0.50 |
| PREFRONTAL CORTEX | interacts_with | concept | 0.50 |
| IL-4 | regulates | concept | 0.50 |
| ISCHEMIC STROKE | regulates | concept | 0.50 |
| CELL DEATH | protects_against | concept | 0.50 |
| BRAIN INFLAMMATION | activates | concept | 0.50 |
| TREM2 RISK VARIANTS | associated_with | concept | 0.50 |
| STRESS GRANULES | associated_with | concept | 0.50 |
| FRONTOTEMPORAL | inhibits | concept | 0.50 |
| MOTOR NEURON | activates | concept | 0.50 |
| Melanoma | activates | disease | 0.50 |
| PIKFYVE | activates | concept | 0.50 |
| FTLD | interacts_with | concept | 0.50 |
| Cachexia | associated_with | disease | 0.50 |
| SPINAL CORD INJURY | associated_with | concept | 0.50 |
| Fatty Liver | regulates | disease | 0.50 |
| Ulcerative Colitis | regulates | disease | 0.50 |
| Prostate Cancer | expressed_in | disease | 0.50 |
| IL-4 | causes | concept | 0.50 |
| PI3K/AKT SIGNALING | regulates | concept | 0.50 |
| Fatty Liver | causes | disease | 0.50 |
| NAFLD | causes | disease | 0.50 |
| CENTRAL NERVOUS SYSTEM | expressed_in | concept | 0.50 |
| Sepsis | inhibits | disease | 0.50 |
| Gut Microbiome | interacts_with | process | 0.50 |
| TAU TANGLES | associated_with | concept | 0.50 |
| PPAR-Γ | associated_with | concept | 0.50 |
| Asthma | inhibits | disease | 0.50 |
| COPD | inhibits | disease | 0.50 |
| TSLP | associated_with | concept | 0.50 |
| BLOOD-BRAIN BARRIER DYSFUNCTION | associated_with | concept | 0.50 |
| Psoriasis | associated_with | disease | 0.50 |
| Myocardial Infarction | regulates | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Abnormal Stress Granule Accumulation | contributes_to | phenotype | 0.90 |
| Redox Signaling | associated_with | process | 0.88 |
| Aberrant Condensates | causes | mechanism | 0.85 |
| Frailty | risk_factor_for | phenotype | 0.85 |
| m6A Modification | associated_with | process | 0.85 |
| Excessive Cell Death | contributes_to | process | 0.80 |
| SIRTUINS | implicated_in | protein | 0.80 |
| Ferroptosis | associated_with | process | 0.80 |
| Ageing | increases_risk | biological_process | 0.80 |
| autophagy | protects_against | process | 0.70 |
| CASP3 | activates | gene | 0.50 |
| EIF2A | activates | protein | 0.50 |
| RPS6KB1 | activates | gene | 0.50 |
| RPTOR | activates | gene | 0.50 |
| PIK3C3 | activates | gene | 0.50 |
| GAPDH | activates | gene | 0.50 |
| ENDOPHILIN | activates | protein | 0.50 |
| VPS34 | activates | protein | 0.50 |
| IFNG | activates | gene | 0.50 |
| MAPK | activates | gene | 0.50 |
| AUTISM | activates | disease | 0.50 |
| TFEB | causes | protein | 0.50 |
| MUL1 | activates | gene | 0.50 |
| TREH | causes | gene | 0.50 |
| MAPK14 | activates | gene | 0.50 |
| LC3B | activates | protein | 0.50 |
| HSPA8 | activates | gene | 0.50 |
| TPP1 | activates | gene | 0.50 |
| cardiomyopathy | activates | disease | 0.50 |
| TARDBP/TDP-43 | activates | protein | 0.50 |
| Neuropathy | associated_with | disease | 0.50 |
| SETX | inhibits | gene | 0.50 |
| ALS4 | inhibits | gene | 0.50 |
| ALS4 | associated_with | gene | 0.50 |
| NPM1 | inhibits | gene | 0.50 |
| XPO1 | inhibits | gene | 0.50 |
| Spinal Cord | activates | cell_type | 0.50 |
| RB1CC1 | activates | gene | 0.50 |
| Tdp-43 | activates | pathway | 0.50 |
| CHOP | activates | gene | 0.50 |
| DRP1 | activates | protein | 0.50 |
| BNIP3L | activates | protein | 0.50 |
| MIRO1 | activates | protein | 0.50 |
| CATALASE | activates | protein | 0.50 |
| PARL | activates | protein | 0.50 |
| HSPA5 | activates | gene | 0.50 |
| DNM1L | activates | gene | 0.50 |
| MFN1 | activates | gene | 0.50 |
| AMPK | activates | protein | 0.50 |
| PGAM5 | activates | concept | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plant-based dietary patterns and Alzheimer's disease risk in multiethn | clinical | Alzheimer's disease and relate | 0.950 | 0.00 | human patients | proposed | N/A |
| SIRPα modulation in mouse models of Alzheimer's disease | validation | Alzheimer's disease | 0.900 | 0.00 | mouse models of Alzheimer's di | proposed | N/A |
| SAHA@LIPO-ANG2 therapeutic efficacy in 5xFAD mice | validation | Alzheimer's disease | 0.900 | 0.00 | 5xFAD transgenic mice | proposed | N/A |
| Transcriptomic profiling and differential expression analysis | exploratory | Alzheimer's disease | 0.900 | 0.00 | 1-month-old APP/PS1 mice cereb | proposed | N/A |
| Microglial SIRPα expression in human Alzheimer's disease tissue | exploratory | Alzheimer's disease | 0.800 | 0.00 | human brain tissue | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655] | Jorstad NL, Close J, Johansen N, Yanny A | Science | 2023 | 186 |
| FAK/SRC-JNK axis promotes ferroptosis via upregulating ACSL4 expression. [PMID:41862445] | Qin J, Ma S, Wang J, Huang S, Luan J, He | Cell death & disease | 2026 | 0 |
| Quercetin attenuates ox-LDL-induced endothelial injury by regulating ferroptosis [PMID:41902795] | Gao C, Liu B, Zhang R, Tian J, Xin H | Toxicology mechanisms and meth | 2026 | 0 |
| NEDD8 promotes the ferritinophagy and ferroptosis of neurons in ischemic stroke [PMID:41662890] | Rao W, Huang Y, Li J, Chen Q, Sun J et a | J Stroke Cerebrovasc Dis | 2026 | 0 |
| Inhibition of Ferroptosis in Prostatitis Model by Low Intensity Extracorporeal S [PMID:41714892] | Lin D, Li K, Kuang W, Chen Z, Zhang M | World J Mens Health | 2026 | 0 |
| Deciphering sorafenib resistance in hepatocellular carcinoma via ferroptotic mec [PMID:41763496] | Che L, Zhu L, Zhou L, Zhou Y | Biochim Biophys Acta Rev Cance | 2026 | 0 |
| B4GALT1 deficiency attenuates steatohepatitis by regulating the PPARγ/ACSL4 axis [PMID:41860570] | Chien Y, Xia R, Zhou D, Ai Y, Wu L et al | Hepatol Commun | 2026 | 0 |
| Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease lin [PMID:41498558] | Singh P, Rath SL | Journal of Alzheimer's disease | 2026 | 0 |
| Resveratrol Alleviates Intervertebral Disc Degeneration by Targeting NCOA4-Media [PMID:41873334] | Song C, Wu X, Chen C, Shen B, He Y, Liu | Drug design, development and t | 2026 | 0 |
| Pan-PPAR agonist bezafibrate alleviates psoriasis by suppressing LCN2-dependent [PMID:41662914] | ["Xin R", "Zhang J", "Zhang Y", "Dai M", | Free radical biology & medicin | 2026 | 0 |
| Acteoside alleviates sepsis-induced acute lung injury by activating the Nrf2 pat [PMID:41895086] | Wang Y, Zhang W, Zhang M, Zhu Y, Wang W, | Tissue & cell | 2026 | 0 |
| Ferroptosis and microglial polarization in retinal vein occlusion: pathological [PMID:41924362] | Xu J, Sun M, Wang C, Ju P, Guan XD, Xie | International journal of ophth | 2026 | 0 |
| Melatonin Alleviates Erastin-Induced Cell Death by Inhibiting Ferroptosis and Am [PMID:40442550] | Wongjaikam S, Siengdee P, Somnus A, Govi | Neurotoxicity research | 2025 | 0 |
| Acyl-CoA synthetase long-chain family member 4-A novel prognostic marker in cuta [PMID:41918944] | Paria S, Lapides R, Saravi B, Rajagopal | Frontiers in medicine | 2025 | 0 |
| Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzhei [PMID:40640358] | Zhu L, Zhou T, Wu L, Zhu X, Chen L, Zhan | Scientific reports | 2025 | 0 |
| Microbiota-derived lysophosphatidylcholine alleviates Alzheimer's disease pathol [PMID:39510074] | ["Zha Xu", "Liu Xicheng", "Wei Mengping" | Cell metabolism | 2025 | 0 |
| Upregulation of MAM by C99 disrupts ACSL4 activity and phospholipid homeostasis [PMID:41394684] | Montesinos J, Yun TD, Salomón-Cruz ID, A | bioRxiv : the preprint server | 2025 | 0 |
| Danggui Shaoyao San ameliorates Alzheimer's disease by regulating lipid metaboli [PMID:40271063] | Gong K, Zhou S, Xiao L, Xu M, Zhou Y, Lu | Frontiers in pharmacology | 2025 | 0 |
| Single-cell spatial transcriptomics reveals distinct patterns of dysregulation i [PMID:39103533] | Johnston KG, Berackey BT, Tran KM, Gelbe | Molecular psychiatry | 2025 | 0 |
| Deferiprone in Alzheimer Disease: A Randomized Clinical Trial. [PMID:39495531] | Ayton S, Barton D, Brew B, Brodtmann A, | JAMA neurology | 2025 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning DISEASE in their description or question text
Score: 0.847 · Alzheimer's Disease · 2026-04-02
## Mechanistic Overview ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia starts from the claim that modu
Score: 0.846 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Optogenetic viral vector delivery via tFUS-mediated blood-brain barrier opening to restore hippo
Score: 0.845 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective SST interneuron activati
Score: 0.827 · Alzheimer's disease · 2026-04-16
## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph
Score: 0.801 · Alzheimer's Disease · 2026-04-05
## Mechanistic Overview ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degeneration in Alzhe
Score: 0.801 · Alzheimer's Disease · 2026-04-05
## Mechanistic Overview 40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively Eliminate Diseas
Score: 0.797 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma f
Score: 0.790 · neurodegeneration · 2026-04-22
## Mechanistic Overview NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic Axis and Dopaminergic Neuron Survival
Score: 0.784 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activate AMPK-autophag
Score: 0.779 · Alzheimer's Disease · 2026-04-05
## Mechanistic Overview LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Priming Engine in Disease-Asso
Score: 0.779 · Alzheimer's Disease · 2026-04-05
## Mechanistic Overview ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlies White Matter D
Score: 0.776 · Alzheimer's Disease · 2026-04-05
## Mechanistic Overview LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Substrate Pools in Disease-Associated M
Score: 0.770 · Alzheimer's Disease · 2026-04-05
## Mechanistic Overview LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability in Disease-Associated Mic
Score: 0.769 · unknown disease · 2026-04-16
## Mechanistic Overview Oligodendrocyte Precursor Cell Senescence in White Matter Disease starts from the claim that mod
Score: 0.767 · Alzheimer's disease · 2026-04-12
## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via somato